Brief: Ascentage Pharma Group International Announces IND Clearance By US FDA
15/06/2021 03:01
June 15 (Reuters) - Ascentage Pharma Group International
6855.HK :
* IND CLEARANCE BY US FDA FOR APG-2575 AS SINGLE AGENT OR IN
COMBINATIONS FOR TREATMENT OF ER+ BREAST CANCER
Source text for Eikon: urn:newsml:reuters.com:*:nHKS3LJx0
Further company coverage: 6855.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ascentage Pharma International
See all newsBrief: Ascentage Pharma Group Says Lisaftoclax Granted Breakthrough Therapy Designation In China
China's Ascentage Pharma climbs as chairman buys shares on market
Brief: Ascentage Pharma Group International's Chairman Buys 38,630 Shares
Brief: Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 Million
China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-up